Abstract
Background
Effective non-invasive ventilation (NIV) is dependent on optimal ventilator settings for alveolar ventilation. Volume-assured pressure support (VAPS) is a mode of servoventilation, providing constant automatic adjustment of pressure support (PS) to achieve a target ventilation.
Objective
To evaluate the effectiveness of volume assured pressure support (VAPS) in comparison with conventional pressure support using S/T mode in-patients with acute hypercapnic respiratory failure due to acute exacerbation of COPD.
Patients and methods
40 patients with hypercapnic respiratory failure and respiratory acidosis due to COPD after failure of standard medical treatment including oxygen therapy were recruited into the study. Patients were categorized into two groups, Group I ventilated with S/T mode and Group II ventilated with VAPS mode. Patients were fitted with an oronasal mask.
Results
Both groups were comparable on admission. The successful outcome was achieved in 15 patients (75%) in the PS group vs 16 patients (80%) in the VAPS group. In the VAPS group, there were a significantly (p < 0.01) higher pH (7.34 ± 0.02 vs 7.31 ± 0.02 for PS group) and significantly (p < 0.001) lower PaCO2 (74.00 ± 2.3 vs 79.00 ± 3.7 for PS group) after 1 h NIV.
There was a significant (p < 0.01) higher minute ventilation and significant (p < 0.001) lower peak inspiratory pressure in the VAPS group after 1 h, and 6 h NIV.
Conclusion
Non invasive VAPS is characterized by stable alveolar ventilation with lower and variable inspiratory pressure and earlier improvement of respiratory acidosis when compared with conventional pressure support.